TORRENT PHARMACEUTICALS
Back to All Ratios
|
TORRENT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 29.89 | 26.60 | 19.66 | 19.38 | 18.62 |
What is the latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | 29.89 |
| Mar2024 | 26.60 |
| Mar2023 | 19.66 |
| Mar2022 | 19.38 |
| Mar2021 | 18.62 |
How is EV/Core EBITDA of TORRENT PHARMACEUTICALS Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 29.89 | 12.37 | |
| Mar2024 | 26.6 | 35.30 | |
| Mar2023 | 19.66 | 1.44 | |
| Mar2022 | 19.38 | 4.08 | |
| Mar2021 | 18.62 | - | |
Other Financial Ratios of TORRENT PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹121,130.3 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
| MANKIND PHARMA | ₹93,419.6 Cr | -5.6% | -5.8% | -11.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.3% |
0.8% |
11.7% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses